{"bekendtgoerelseNoegle":{"noticeId":{"value":"7e388325-c161-4992-b75e-f4d2dd478845"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00080500-2025"}},"htmlDA":"\n\n \n 1 Køber1.1 KøberOfficielt navn: Region Syddanmark\n Køberens retlige status: Regional myndighed\n Den ordregivende myndigheds aktiviteter: Sundhed\n \n \n 2 Procedure2.1 ProcedureTitel: Markedsundersøgelse af Vagus nervestimulator\n Beskrivelse: The Region of Southern Denmark is assisting The Danish Healthcare Quality Institute\n (DHQI) in conducting a market consultation about the existence of any CE marked technologies\n for the treatment of cluster headache. This is the case because DHQI is conducting\n an assessment of non-invasive vagus nerve stimulation (nVNS) technologies for the\n treatment of cluster headache. The overall purpose of the DHQI is to assess new or\n existing health technologies to ensure most value for money in the delivery of treatments\n in the Danish healthcare system. A horizon scanning of international HTA-organizations\n revealed a single technology assessment from the Norwegian Institute of Public Health\n (NIPH) of transcutaneous non-invasive vagus nerve stimulation (gammaCore) for the\n treatment of cluster headache. gammaCore is a Class IIa therapeutic medical device.\n The treatment modality delivered by gammaCore is non-invasive vagus nerve stimulation,\n nVNS, (also: transcutaneous vagus nerve stimulation, tVNS). As part of the evaluation,\n the DHQI needs to know if other companies provide this, or a similar CE marked technology.\n With a similar technology, we mean a technology that delivers nVNS to treat cluster\n headache. We do not mean implantable nerve stimulation technologies or technologies\n that stimulates other nerves than the vagus nerve for the treatment of cluster headache.\n Please contact procurement officer Kent Melgaard Nielsen, kent.melgaard.nielsen@rsyd.dk\n in case your company provides the abovementioned CE marked technology. You will in\n return be asked to provide documentation for your technology to be included in the\n DHQI evaluation. We will appreciate your reply on 17th of February 2025 at the latest.\n Intern identifikator: 1240\n 2.1.1 Formål\n Primær klassificering (cpv): 33158000 Elektrisk, elektromagnetisk og mekanisk terapi\n Yderligere klassificering (cpv): 33158210 Stimulator\n \n \n 2.1.4 Generelle oplysninger\n \n \n \n \n 8 Organisationer8.1 ORG-0001Officielt navn: Region Syddanmark\n Registreringsnummer: 29190909\n \n \n \n Landespecifik underafdeling (NUTS): Sydjylland (DK032)\n \n Kontaktpunkt: Kent Nielsen\n E-mail: Kent.melgaard.nielsen@rsyd.dk\n \n Internetadresse: https://www.regionsyddanmark.dk\n Køberprofil: https://eu.eu-supply.com/ctm/company/companyinformation/index/181055\n Denne organisations roller:\n \n \n 8.1 ORG-0002Officielt navn: Mercell Holding ASA\n Registreringsnummer: 980921565\n Postadresse: Askekroken 11 \n \n \n Landespecifik underafdeling (NUTS): Oslo (NO081)\n \n \n E-mail: publication@mercell.com\n \n \n Internetadresse: http://mercell.com/\n Denne organisations roller:\n \n \n \n 11 Oplysninger om bekendtgørelsen11.1 Oplysninger om bekendtgørelsenIdentifikator for bekendtgørelsen: 7e388325-c161-4992-b75e-f4d2dd478845 - 01\n Formulartype: Planlægning\n Bekendtgørelsestype: Bekendtgørelse om offentliggørelse af en forhåndsmeddelelse eller en vejledende periodisk bekendtgørelse i en køberprofil\n Bekendtgørelsessubtype: 1\n Afsendelsesdato for bekendtgørelsen: 03-02-2025 12:38 +00:00\n Dato for afsendelse af bekendtgørelse (eSender): 03-02-2025 14:00 +00:00\n Sprog, som denne bekendtgørelse er officielt tilgængelig på: dansk \n \n 11.2 Oplysninger om offentliggørelsenBekendtgørelsesnummer: 00080500-2025\n \n Offentliggørelsesdato: 05-02-2025\n \n \n \n","htmlEN":"\n\n \n 1 Buyer1.1 BuyerOfficial name: Region Syddanmark\n Legal type of the buyer: Regional authority\n Activity of the contracting authority: Health\n \n \n 2 Procedure2.1 ProcedureTitle: Markedsundersøgelse af Vagus nervestimulator\n Description: The Region of Southern Denmark is assisting The Danish Healthcare Quality Institute\n (DHQI) in conducting a market consultation about the existence of any CE marked technologies\n for the treatment of cluster headache. This is the case because DHQI is conducting\n an assessment of non-invasive vagus nerve stimulation (nVNS) technologies for the\n treatment of cluster headache. The overall purpose of the DHQI is to assess new or\n existing health technologies to ensure most value for money in the delivery of treatments\n in the Danish healthcare system. A horizon scanning of international HTA-organizations\n revealed a single technology assessment from the Norwegian Institute of Public Health\n (NIPH) of transcutaneous non-invasive vagus nerve stimulation (gammaCore) for the\n treatment of cluster headache. gammaCore is a Class IIa therapeutic medical device.\n The treatment modality delivered by gammaCore is non-invasive vagus nerve stimulation,\n nVNS, (also: transcutaneous vagus nerve stimulation, tVNS). As part of the evaluation,\n the DHQI needs to know if other companies provide this, or a similar CE marked technology.\n With a similar technology, we mean a technology that delivers nVNS to treat cluster\n headache. We do not mean implantable nerve stimulation technologies or technologies\n that stimulates other nerves than the vagus nerve for the treatment of cluster headache.\n Please contact procurement officer Kent Melgaard Nielsen, kent.melgaard.nielsen@rsyd.dk\n in case your company provides the abovementioned CE marked technology. You will in\n return be asked to provide documentation for your technology to be included in the\n DHQI evaluation. We will appreciate your reply on 17th of February 2025 at the latest.\n Internal identifier: 1240\n 2.1.1 PurposeMain nature of the contract: Supplies\n Main classification (cpv): 33158000 Electrical, electromagnetic and mechanical treatment\n Additional classification (cpv): 33158210 Stimulator\n \n 2.1.2 Place of performance\n \n 2.1.4 General information\n \n \n \n \n 8 Organisations8.1 ORG-0001Official name: Region Syddanmark\n Registration number: 29190909\n Postal address: Damhaven 12 \n \n \n Country subdivision (NUTS): Sydjylland (DK032)\n \n Contact point: Kent Nielsen\n Email: Kent.melgaard.nielsen@rsyd.dk\n \n Internet address: https://www.regionsyddanmark.dk\n Buyer profile: https://eu.eu-supply.com/ctm/company/companyinformation/index/181055\n Roles of this organisation:\n \n \n 8.1 ORG-0002Official name: Mercell Holding ASA\n Registration number: 980921565\n Postal address: Askekroken 11 \n \n \n Country subdivision (NUTS): Oslo (NO081)\n \n \n Email: publication@mercell.com\n \n \n Internet address: http://mercell.com/\n Roles of this organisation:\n \n \n \n 11 Notice information11.1 Notice informationNotice identifier/version: 7e388325-c161-4992-b75e-f4d2dd478845 - 01\n \n Notice type: Notice of the publication of a prior information notice or a periodic information notice on a buyer profile\n \n Notice dispatch date: 03-02-2025 12:38 +00:00\n Notice dispatch date (eSender): 03-02-2025 14:00 +00:00\n Languages in which this notice is officially available: Danish \n \n 11.2 Publication informationNotice publication number: 00080500-2025\n OJ S issue number: 25/2025\n Publication date: 05-02-2025\n \n \n \n","opsummeringDA":{"card":{"titel":"Markedsundersøgelse af Vagus nervestimulator","ordregiver":"Region Syddanmark","ordregiverId":"29190909","ordregiverIdDatavasket":"29190909","publiceringsdato":"2025-02-05+01:00","cpvKode":"33158000","cpvTitel":"Elektrisk, elektromagnetisk og mekanisk terapi","formulartype":"Planlægning","formulartypeKode":"planning","tidsfrister":[],"alleOrdregivere":["Region Syddanmark"],"beskrivelse":"The Region of Southern Denmark is assisting The Danish Healthcare Quality Institute (DHQI) in conducting a market consultation about the existence of any CE marked technologies for the treatment of cluster headache. This is the case because DHQI is conducting an assessment of non-invasive vagus nerve stimulation (nVNS) technologies for the treatment of cluster headache. The overall purpose of the DHQI is to assess new or existing health technologies to ensure most value for money in the delivery of treatments in the Danish healthcare system. A horizon scanning of international HTA-organizations revealed a single technology assessment from the Norwegian Institute of Public Health (NIPH) of transcutaneous non-invasive vagus nerve stimulation (gammaCore) for the treatment of cluster headache. gammaCore is a Class IIa therapeutic medical device. The treatment modality delivered by gammaCore is non-invasive vagus nerve stimulation, nVNS, (also: transcutaneous vagus nerve stimulation, tVNS). As part of the evaluation, the DHQI needs to know if other companies provide this, or a similar CE marked technology. With a similar technology, we mean a technology that delivers nVNS to treat cluster headache. We do not mean implantable nerve stimulation technologies or technologies that stimulates other nerves than the vagus nerve for the treatment of cluster headache. Please contact procurement officer Kent Melgaard Nielsen, kent.melgaard.nielsen@rsyd.dk in case your company provides the abovementioned CE marked technology. You will in return be asked to provide documentation for your technology to be included in the DHQI evaluation. We will appreciate your reply on 17th of February 2025 at the latest.","bkSubTypeKode":"1","bkSubType":"Bekendtgørelse om offentliggørelse af en forhåndsmeddelelse i en køberprofil – det generelle direktiv","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":[],"udforelsesstedSubLand":[],"udforelsesstedLand":[],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":0,"antalLots":0,"udbudsDokumenter":[]},"opsummeringEN":{"card":{"titel":"Markedsundersøgelse af Vagus nervestimulator","ordregiver":"Region Syddanmark","ordregiverId":"29190909","ordregiverIdDatavasket":"29190909","publiceringsdato":"2025-02-05+01:00","cpvKode":"33158000","cpvTitel":"Electrical, electromagnetic and mechanical treatment","formulartype":"Planning","formulartypeKode":"planning","tidsfrister":[],"alleOrdregivere":["Region Syddanmark"],"beskrivelse":"The Region of Southern Denmark is assisting The Danish Healthcare Quality Institute (DHQI) in conducting a market consultation about the existence of any CE marked technologies for the treatment of cluster headache. This is the case because DHQI is conducting an assessment of non-invasive vagus nerve stimulation (nVNS) technologies for the treatment of cluster headache. The overall purpose of the DHQI is to assess new or existing health technologies to ensure most value for money in the delivery of treatments in the Danish healthcare system. A horizon scanning of international HTA-organizations revealed a single technology assessment from the Norwegian Institute of Public Health (NIPH) of transcutaneous non-invasive vagus nerve stimulation (gammaCore) for the treatment of cluster headache. gammaCore is a Class IIa therapeutic medical device. The treatment modality delivered by gammaCore is non-invasive vagus nerve stimulation, nVNS, (also: transcutaneous vagus nerve stimulation, tVNS). As part of the evaluation, the DHQI needs to know if other companies provide this, or a similar CE marked technology. With a similar technology, we mean a technology that delivers nVNS to treat cluster headache. We do not mean implantable nerve stimulation technologies or technologies that stimulates other nerves than the vagus nerve for the treatment of cluster headache. Please contact procurement officer Kent Melgaard Nielsen, kent.melgaard.nielsen@rsyd.dk in case your company provides the abovementioned CE marked technology. You will in return be asked to provide documentation for your technology to be included in the DHQI evaluation. We will appreciate your reply on 17th of February 2025 at the latest.","bkSubTypeKode":"1","bkSubType":"Notice of the publication of a prior information notice on a buyer profile – general directive","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":[],"udforelsesstedSubLand":[],"udforelsesstedLand":[],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":0,"antalLots":0,"udbudsDokumenter":[]}}